Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.6%

4 terminated out of 61 trials

Success Rate

89.5%

+3.0% vs benchmark

Late-Stage Pipeline

18%

11 trials in Phase 3/4

Results Transparency

15%

5 of 34 completed with results

Key Signals

5 with results89% success

Data Visualizations

Phase Distribution

39Total
Not Applicable (19)
P 1 (2)
P 2 (7)
P 3 (6)
P 4 (5)

Trial Status

Completed34
Unknown15
Terminated4
Not Yet Recruiting3
Withdrawn3
Recruiting2

Trial Success Rate

89.5%

Benchmark: 86.5%

Based on 34 completed trials

Clinical Trials (61)

Showing 20 of 20 trials
NCT02139163RecruitingPrimary

Epidemiological Study on Community Acquired Pneumonia

NCT07425561Completed

Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

NCT07336121Not ApplicableCompletedPrimary

HVNI vs CPAP in Children With Acute Respiratory Distress

NCT06986148Not ApplicableRecruiting

Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)

NCT07317440Not ApplicableNot Yet RecruitingPrimary

Coenzyme Q10 in Pediatric Community-Acquired Pneumonia

NCT07315555Not ApplicableNot Yet RecruitingPrimary

Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma

NCT02517489Phase 3CompletedPrimary

Community-Acquired Pneumonia : Evaluation of Corticosteroids

NCT07109310Not Yet Recruiting

A Validation Study on a Prognostic Prediction Model for Respiratory Tract Infections

NCT06210282Not ApplicableCompleted

The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice

NCT06642701Not ApplicableCompletedPrimary

Electrical Impedance Imaging Techniques in Guiding the Use of Chest Physiotherapy in Patients with Pneumonia

NCT04198571CompletedPrimary

Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries

NCT02454114Not ApplicableCompletedPrimary

HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections

NCT02880384Not ApplicableCompletedPrimary

Pathogen Detection and Community Acquired Pneumonia

NCT01964495Not ApplicableCompletedPrimary

Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)

NCT03411824CompletedPrimary

Lung Ultrasound for Community-acquired Pneumonia Diagnosis in Emergency Medicine

NCT03475732Not ApplicableCompleted

Pharmacokinetics of XueBiJing in Patients With Sepsis

NCT04158310UnknownPrimary

Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children

NCT02813694Phase 3CompletedPrimary

Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia

NCT02559310Phase 3CompletedPrimary

Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia

NCT02963142CompletedPrimary

A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia

Scroll to load more

Research Network

Activity Timeline